These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16963864)

  • 41. Thrombophilia in the occurrence of retinal vascular infarction after photodynamic therapy with verteporfin using the standard protocol.
    Parmeggiani F; Gemmati D; Costagliola C
    Arch Ophthalmol; 2010 Dec; 128(12):1632; author reply 1632-3. PubMed ID: 21149800
    [No Abstract]   [Full Text] [Related]  

  • 42. Combined photodynamic therapy and intravitreal triamcinolone injection for choroidal neovascularization in Best disease.
    Nóbrega M; Bortolotto C; Farah M
    Can J Ophthalmol; 2007 Oct; 42(5):761-2. PubMed ID: 17891211
    [No Abstract]   [Full Text] [Related]  

  • 43. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
    Arevalo JF; Ruiz-Moreno JM; Fernandez CF; Mendoza AJ; Ramirez E; Montero JA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):58-62. PubMed ID: 14750766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concentric retinal pigment epithelium atrophy after a single photodynamic therapy.
    Wachtlin J; Behme T; Heimann H; Kellner U; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2003 Jun; 241(6):518-21. PubMed ID: 12734707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen.
    Chaudhry NA; Lavaque AJ; Shah A; Liggett PE
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):70-2. PubMed ID: 15688974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to focal laser photocoagulation for radiation retinopathy.
    Bakri SJ; Beer PM
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):475-7. PubMed ID: 14620753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute respiratory distress due to verteporfin infusion for photodynamic therapy.
    Fossarello M; Peiretti E
    Arch Ophthalmol; 2006 Oct; 124(10):1509-10. PubMed ID: 17030732
    [No Abstract]   [Full Text] [Related]  

  • 49. Competitive quenching: a possible novel approach in protecting RPE cells from damage during PDT.
    Weinberger D; Ron Y; Lusky M; Gaaton D; Orenstein A; Blank M; Mandel M; Livnat T; Barliya T; Lavie G
    Curr Eye Res; 2005 Apr; 30(4):269-77. PubMed ID: 16020257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute severe vision decrease immediately after photodynamic therapy.
    Beaumont P; Lim CS; Chang A; Kang K
    Arch Ophthalmol; 2004 Oct; 122(10):1546-7. PubMed ID: 15477472
    [No Abstract]   [Full Text] [Related]  

  • 51. Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome.
    Kang SW; Kang SJ; Kim HO; Nam ES; Lee JH; Koh HJ
    Am J Ophthalmol; 2002 Dec; 134(6):907-8. PubMed ID: 12470762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Accidental pregnancy exposure to verteporfin: obstetrical and neonatal outcomes: a case report.
    Rodrigues M; Meira D; Batista S; Carrilho MM
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):236-7. PubMed ID: 19432621
    [No Abstract]   [Full Text] [Related]  

  • 53. Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.
    Csaky KG; Richman EA; Ferris FL
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):479-89. PubMed ID: 18234989
    [No Abstract]   [Full Text] [Related]  

  • 54. Burns after photodynamic therapy.
    Hettiaratchy S; Clarke J; Taubel J; Besa C
    BMJ; 2000 May; 320(7244):1245. PubMed ID: 10797034
    [No Abstract]   [Full Text] [Related]  

  • 55. Burns after photodynamic therapy. Drug point gives misleading impression of incidence of burns with temoporfin (Foscan).
    Bryce R
    BMJ; 2000 Jun; 320(7251):1731-2. PubMed ID: 10917711
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypomelanosis of Ito.
    Reese PD; Judisch GF
    Arch Ophthalmol; 1986 Aug; 104(8):1136-7. PubMed ID: 3741241
    [No Abstract]   [Full Text] [Related]  

  • 57. Gene Therapy in the Treatment of Geographic Atrophy.
    Csaky KG
    Int Ophthalmol Clin; 2021 Oct; 61(4):241-247. PubMed ID: 34584060
    [No Abstract]   [Full Text] [Related]  

  • 58. Photosensitizing drugs and their possible role in enhancing ocular toxicity. Parker Heath memorial lecture.
    Lerman S
    Ophthalmology; 1986 Mar; 93(3):304-18. PubMed ID: 3085038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal response of the retinal pigment epithelium to photodynamic therapy in a child.
    Diaz M; Cervera E; Hernandez M; Salom D
    Retina; 2006 Sep; 26(7):834-6. PubMed ID: 16963864
    [No Abstract]   [Full Text] [Related]  

  • 60. Retinopathy associated with photodynamic therapy for treatment of idiopathic choroidal neovascularization.
    Sii F; Lee LR
    Clin Exp Ophthalmol; 2006 Mar; 34(2):184-6. PubMed ID: 16626441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.